KalVista's Genetic Disease Treatment Triumphs in Late-Stage Study

DelSiTech Ltd., a pharmaceutical development and supply company, and Tolmar International Ltd., a fully integrated pharmaceutical company, have strengthened their partnership by signing a global licensing and development agreement following Tolmar's

Torus Health & Tata 1mg Collaborate for Comprehensive Healthcare

Torus Health has partnered with Tata 1mg to create a unique new solution in the healthcare industry. An innovative initiative by Torus Group, a subsidiary of Cosmea Financial Holdings Pvt Ltd, is about to revolutionize India's health and wellness

IAP's launched Child Health Campaign: 'IAP Ki Baat, Community Ke Saath

The Indian Pediatric Association (IAP) has launched a pioneering program called 'IAP Ki Baat, Community Ke Saath' to engage the community actively and provide valuable information on child health.

Roche & Pathai Expand Digital Pathology for Diagnostics

Roche announced that it has signed an agreement with PathAI, a world leader in artificial intelligence (AI)-based pathology technologies.

Eris Lifesciences Buys 51% in Swiss Parenterals To Expand Sterile Injectables

Eris Lifesciences Ltd., an Indian marked plans organization, reported the extension of its Sterile Injectables impression through the securing of 51% value stake in Swiss Parenterals Ltd. for a thought of Rs.637.50 crore. As per a press...

Anixa Biosciences Initiates Second Ovarian Cancer CAR-T Trial Dosing

Anixa Biosciences, Inc., a clinical technology company focused on treating and preventing cancer, announced that it has started treatment for the fourth patient in its Phase 1 clinical trial of its novel T cell chimeric antigen receptor (CAR-T)

Supriya Life science Wins 8 Gold Awards at Maharashtra State Export Event

Supriya Life science Limited, a global leader in the manufacture of Active Pharmaceutical Ingredients (APIs), has achieved a major achievement by bagging the 8th Gold Award at the Maharashtra State

Mankind Pharma Partners with Lepra Society to Screen 80,000 for Leprosy

Mankind Pharma, an Indian pharmaceutical company, has announced a strategic partnership with the Lepra Society to launch a comprehensive campaign to eradicate, raise awareness, and cure leprosy.

DA Breakthrough Designation for AlphaMedix in Neuroendocrine Tumors

RadioMedix, Inc., a Houston-based clinical technology company and sponsor of the AlphaMedix clinical trial, and Orano Med, a clinical biotechnology company developing next-generation cancer therapies

© 2025 India Pharma Outlook. All Rights Reserved.